Apollo and Oxford University enter drug discovery and development collaboration
The latest collaboration marks Apollo’s sixth agreement with a research institution
Read More
Tag: Apollo Therapeutics
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
